Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Redwood City, California, dedicated to developing innovative therapies for rare diseases. With a strong emphasis on addressing unmet medical needs, Soleno leverages its proprietary drug development platform to advance treatments through clinical trials. The company's commitment to therapeutic innovation positions it as a key player in the rare disease space, making it an intriguing investment opportunity for institutional investors seeking exposure to cutting-edge biopharmaceutical advancements.